Co-culturing of anti-carcinoembryonic antigen (CEA)-specific CAR T cells and CEA-positive LS174T colorectal cancer cells in the presence of IL-7/IL-12-engineered MSCs resulted in enhanced CAR T-cell-driven anti-tumor immune response. The gene discussed is CEACAM5; the disease is neoplasm.